This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...